ClinicalTrials.gov
public full text
Public Domain
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
This is a 12-week, multi-center, open-label extension study designed to evaluate the longer-term safety, tolerability and effectiveness of lurasidone for the treatment of subjects with schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension#897666
- Advance directives in patients with schizophrenia.#148475
- Ziprasidone in the Psychosis Prodrome#864389
- L-arginine in Treatment as Usual in Schizophrenia#850326
- A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia#833587
Record · ID 1163207
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive